7th Cell Therapy Analytical Development Summit
December 1 - 3, 2025 - MA USHanson Wade
info@hansonwade.com
Phone:+44 (0)20 3141 8700
With robust, reliable and regulatory-ready analytics lying at the heart of clinically successful cell therapies, now is the time to elevate your current workflows and strategies to prepare for clinical and commercial readiness. Remaining the industry’s leading forum for cell therapy analytical, quality control, assay, and CMC professionals, the 7th Cell Therapy Analytical Development Summit will delve into cutting-edge technologies and proven strategies to aid you in demonstrating product safety, functionality, and quality before heading to market. Focus your learning and address your specific needs with our refined two-track format, covering early- to late-stage assay development. No matter where you are in the product development cycle, gain hands-on expertise from designing predictive potency assays, through to validating and transferring methods for late-phase trials. Featuring first-hand case studies and experiences from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the National Institute of Health, seize the opportunity to benchmark against peers, exchange solutions to persistent challenges, and strengthen your analytical toolkit, to excel in an increasingly competitive cell therapy landscape. Time: 8:00 AM - 5:00 PM